Correction: Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins

PLoS ONE 2026 Open access

Read full text
Authors: Hanadi M. Baeissa, Tahani Bakhsh, Afnan Mohammed Shakoori, Ghadir Sindi, Randa Mohammed Zaki, Mohammad Azhar Kamal, Hadeel Ahmed Alsufyani, Alaa Hamed Habib, Arwa Ishaq A. Khayyat, Misbahuddin Rafeeq, Deeba Shamim Jairajpuri
DOI: 10.1371/journal.pone.0344592
Cited by: 0
References: 1

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0334013.].

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Computational Drug Discovery Methods Cancer Mechanisms and Therapy

Publication details

Journal / source
PLoS ONE
Volume
21
Issue
3
Pages
e0344592–e0344592
Publication date
9 March 2026
Language
EN